【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Market Landscape
06.1 Market Overview
07.Global Active Pharmaceutical Ingredients Market
07.1 Market Size and Forecast
07.2 Five Forces Analysis
08.Market Segmentation by Type of Production Process
08.1 Global Market for Synthetically Produced Active Pharmaceutical Ingredients
08.1.1 Market Size and Forecast
08.2 Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients
08.2.1 Market Size and Forecast
08.2.2 Market Segmentation by Type of Product
09.Market Segmentation by Type of Product
09.1 Global High-potency Active Pharmaceutical Ingredients Market
09.1.1 Market Size and Forecast
09.1.2 Market Segmentation by Type of Production Process
09.1.3 Market Segmentation by Type of Product
10.Market Segmentation by Type of Player
10.1 Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product
11.Geographical Segmentation
11.1 Active Pharmaceutical Ingredients Market in Americas
11.1.1 Market Size and Forecast
11.2 Active Pharmaceutical Ingredients Market in APAC Region
11.2.1 Market Size and Forecast
11.3 Active Pharmaceutical Ingredients Market in EMEA Region
11.3.1 Market Size and Forecast
12.Key Leading Countries
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.2 Key Vendors 2014
20.3 Other Prominent Vendors
20.3.1 Abbott Laboratories
20.3.2 Actavis
20.3.3 Aesica
20.3.4 Albemarle
20.3.5 AMPAC Fine Chemicals
20.3.6 Anhui Biochem United Pharmaceutical
20.3.7 Anuh Pharma
20.3.8 Aptuit
20.3.9 AstraZeneca
20.3.10 Biocon
20.3.11 Bristol-Myers Squibb
20.3.12 Calyx Chemicals & Pharmaceuticals
20.3.13 Cambrex
20.3.14 Cilag
20.3.15 CIRON Drugs and Pharmaceuticals
20.3.16 CTX Life Sciences
20.3.17 Dishman Pharmaceuticals & Chemicals
20.3.18 Dr. Paul Lohmann
20.3.19 Emcure Pharmaceuticals
20.3.20 Farmabios
20.3.21 F. Hoffmann-La Roche
20.3.22 GlaxoSmithKline
20.3.23 Guilin Pharmaceutical
20.3.24 Hetero Drugs
20.3.25 Hospira
20.3.26 Ipca Laboratories
20.3.27 Janssen Pharmaceutica
20.3.28 Johnson Matthey
20.3.29 Laurus Labs
20.3.30 Lupin
20.3.31 Mallinckrodt Pharmaceuticals
20.3.32 Mangalam Drugs & Organics
20.3.33 Merck
20.3.34 Mylan
20.3.35 Novartis
20.3.36 Novasep
20.3.37 Pen Tsao Chemical Industry
20.3.38 Pfizer
20.3.39 Ranbaxy Laboratories
20.3.40 Royal DSM
20.3.41 Sanofi-Aventis
20.3.42 Sequent Scientific
20.3.43 Shanghai Desano Chemical Pharmaceutical
20.3.44 Shasun
20.3.45 Shijiazhuang Lonzeal Pharmaceuticals
20.3.46 Sigma-Aldrich
20.3.47 ST Pharm
20.3.48 Sun Pharmaceutical Industries
20.3.49 WuXi AppTec
20.3.50 Zhejiang Langhua Pharmaceutical
20.3.51 Zhuhai Rundu Pharmaceutical
21.Key Vendor Analysis
21.1 Aurobindo Pharma
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation
21.1.4 Geographical Segmentation by Revenue 2014
21.1.5 Business Strategy
21.1.6 Recent Developments
21.1.7 SWOT Analysis
21.2 BASF
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business/Product Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Boehringer Ingelheim
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2013
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Geographical Segmentation by Revenue 2013
21.3.6 Business Strategy
21.3.7 Recent Developments
21.3.8 SWOT Analysis
21.4 Cipla
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Product Segmentation
21.4.4 Geographical Segmentation by Revenue 2014
21.4.5 Business Strategy
21.4.6 Recent Developments
21.4.7 SWOT Analysis
21.5 Dr. Reddy’s Laboratories
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2014
21.5.4 Business Segmentation by Revenue 2013 and 2014
21.5.5 Geographical Segmentation by Revenue 2014
21.5.6 Business Strategy
21.5.7 Recent Developments
21.5.8 SWOT Analysis
21.6 Lonza Group
21.6.1 Key Facts
21.6.2 Business Overview
21.6.3 Business Segmentation by Revenue 2013
21.6.4 Business Segmentation by Revenue 2012 and 2013
21.6.5 Geographical Segmentation by Revenue 2013
21.6.6 Business Strategy
21.6.7 Recent Developments
21.6.8 SWOT Analysis
21.7 Teva Pharmaceutical Industries
21.7.1 Key Facts
21.7.2 Business Overview
21.7.3 Business Segmentation
21.7.4 Business Segmentation by Revenue 2013
21.7.5 Business Segmentation by Revenue 2012 and 2013
21.7.6 Sales by Geography
21.7.7 Business Strategy
21.7.8 Key Developments
21.7.9 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Active Pharmaceutical Ingredients Market Segmentation
Exhibit 3: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process
Exhibit 4: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product
Exhibit 5: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player
Exhibit 6: Global Active Pharmaceutical Ingredients Market Segmentation by Geography
Exhibit 7: Global Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
Exhibit 8: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
Exhibit 9: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014-2019
Exhibit 10: Global Market for Synthetically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
Exhibit 11: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
Exhibit 12: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients: Segmentation by Type of Product 2014
Exhibit 13: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 14: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014-2019
Exhibit 15: Global High-potency Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
Exhibit 16: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
Exhibit 17: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 18: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player 2014
Exhibit 19: Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 20: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014
Exhibit 21: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014-2019
Exhibit 22: Active Pharmaceutical Ingredients Market in Americas 2014-2019 (US$ billion)
Exhibit 23: Active Pharmaceutical Ingredients Market in Americas: Segmentation by Key Leading Country 2014
Exhibit 24: Active Pharmaceutical Ingredients Market in APAC Region 2014-2019 (US$ billion)
Exhibit 25: Active Pharmaceutical Ingredients Market in APAC Region: Segmentation by Key Leading Country 2014
Exhibit 26: Active Pharmaceutical Ingredients Market in EMEA Region 2014-2019 (US$ billion)
Exhibit 27: Active Pharmaceutical Ingredients Market in EMEA Region: Segmentation by Key Leading Countries 2014
Exhibit 28: Global Active Pharmaceutical Ingredients Market: Key Leading Countries 2014
Exhibit 29: WHO’s List of Prequalified Active Pharmaceutical Ingredients (22nd October, 2014)
Exhibit 30: Aurobindo Pharma: Business Segmentation
Exhibit 31: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
Exhibit 32: BASF: Business Segmentation 2013
Exhibit 33: BASF: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 34: BASF: Geographical Segmentation by Revenue 2013
Exhibit 35: Boehringer Ingelheim: Business Segmentation by Revenue 2013
Exhibit 36: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 37: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
Exhibit 38: Cipla: Product Segmentation
Exhibit 39: Cipla: Geographical Segmentation by Revenue 2014
Exhibit 40: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2014
Exhibit 41: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
Exhibit 42: Dr. Reddy’s Laboratories: Geographical Segmentation by Revenue 2014
Exhibit 43: Lonza Group: Business Segmentation by Revenue 2013
Exhibit 44: Lonza Group: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 45: Lonza Group: Geographical Segmentation by Revenue 2013
Exhibit 46: Teva Pharmaceutical Industries: Business Segmentation
Exhibit 47: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
Exhibit 48: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 49: Teva Pharmaceutical Industries: Sales by Geography 2013
【レポート販売概要】
■ タイトル：医薬品有効成分（原薬/API）の世界市場■ 英文：Global Active Pharmaceutical Ingredients Market 2015-2019
■ 発行日：2014年12月10日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4885
■ 調査対象地域：グローバル
- プラダーウィリ症候群治療の世界市場2018-2022About this market The number of pipeline molecules in the global PWS therapeutics market is increasing at a good phase. The pipeline has many promising therapeutics agents, which are expected to boost the market growth. According to industry experts, approximately 15 therapeutics, are under different stages of development in the pipeline. The number of clinical trials is continuously increasing fo …
- 商用車用テレマティクスの世界市場2016-2026The latest report from business intelligence provider visiongain offers comprehensive insight into the global commercial vehicle telematics market. Visiongain assesses that this market will generate revenues of more than $13bn in 2016. The commercial vehicle telematics industry is undeniably one of the fastest growing sectors in the commercial vehicles sector. Now: TomTom Telematics will be highli …
- 髄膜腫：グローバル臨床試験レビュー（2014年上半期）Meningioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Meningioma Global Clinical Trials Review, H1, 2014" provides data on the Meningioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Meningioma. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- 世界における小型自動車用シート市場動向と予測（～2029）This latest just-auto report edition offers a global review of the OE seating sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE seating market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects Marke …
- 高吸水性高分子（SAP）の世界市場予測（～2024年）“The super absorbent polymers market is projected to grow at a CAGR of 7.4% between 2019 and 2024.” The super absorbent polymers market is projected to grow from USD 9.0 billion in 2019 to USD 12.9 billion by 2024, at a CAGR of 7.4%. The increased demand for SAP in applications such as personal hygiene, agriculture, medical, and industrial is expected to drive the growth of the super absorbent pol …
- ノルマルブタノールの世界市場動向及び予測N-butanol (C4H9OH) or n-butyl alcohol or normal butanol is a clear colorless flammable liquid. It is readily biodegradable with low level of toxicity. N-butanol is used as a feedstock for manufacturing various chemicals including butyl acrylate, butyl acetate, glycol ethers, and plasticizers. It is also used as direct solvent for paints, coatings, varnishes, resins, dyes, camphor, vegetable oils, …
- 工業用繊維品の世界市場分析：技術別（熱成形、3D製織、3D編み、ナノファイバー、ヒートセット合成、仕上げ処理、手作りエレメント）、エンドユーザー別（車両関係、機械関係、スポーツ関係、建設関係、インテリア関係、布関係、医療関係、農業関係、防護関係、包装関係）、セグメント予測The global technical textiles market is expected to reach USD 193.16 billion by 2022, according to a new report by Grand View Research, Inc. Growth of key end-use industries such as agriculture, construction, packaging and automotive in BRIC nations is expected to remain a key driving factor for global technical textiles market. Being one of the most innovative branches of industry across the worl …
- アメリカのSSL証明書市場2016-2020About the Secured Socket Layer (SSL) Certification Market in the US SSL is a paradigm technology for the secure transmission of data between a client (web browser) and a server (web server). • SSL creates an encrypted link between a web browser and a web server, which allows secure data transmission. • It is a security protocol that uses algorithms to determine variables of the encryption for both …
- 世界のバイオマス市場：市場機会、動向、課題分析Over the years to come, biomass will grow within the biopower, biofuels, and bioproduct sectors. About 70% of all biomass in the world is used in the residential sector, while 14% is used in industry and 11% is transformed into electricity, heat, or another energy carrier such as liquid fuel or biogas. Under the present market conditions, the majority of available renewable power resources includi …
- ICT予算及び人員配置動向：製薬産業部門- 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers. What is the current market landscape and what is changing? Kable’s survey shows that overall ICT spending in the pharmaceutical sector is set to increase in 2013 compared to 2012, with the highest proportion of the average ICT budget being allocated to hardware, followed …
- 植物エキスの世界市場予測（～2025年）“The plant extracts market is projected to grow at a CAGR of 16.5%.” According to MarketsandMarkets analysis, the plant extracts market is estimated to be valued at USD 23.7 billion in 2019 and is projected to reach USD 59.4 billion by 2025, at a CAGR of 16.5% from 2019 to 2025. Factors such as rising awareness regarding the side-effects of synthetic flavors and health benefits offered by phytomed …
- 大人用おむつの世界市場：製品種類別（パンツタイプ、パッドタイプ、テープタイプ、その他）、流通経路別（オフライン＆オンライン）The global adult diapers market was valued at $13.3 billion in 2018 and is projected to reach $24.1 billion by 2026, growing at a CAGR of 7.8% from 2019 to 2026. The global adult diapers market is segmented on the basis of product type, distribution channel, and region. By product type, the market is classified into pant type, pad type, tape, and others. By distribution channel, the market is divi …
- 血管形成術用バルーンの世界市場分析：タイプ別（通常のバルーン、薬物溶出バルーン、切断バルーン、スコアリングバルーン）、用途別（末梢、冠動脈）、エンドユーザー別、地域別、セグメント予測 2013 – 2024The global angioplasty balloon market is expected to reach a value of USD 2.9 billion by 2024, according on a new report by Grand View Research, Inc. The growth of the market is attributed to favorable government policies, approval & commercialization of several angioplasty balloons, and increasing coronary & peripheral interventions. Angioplasty is a minimally invasive procedure, hence patients a …
- Otto Energy Limited社の石油・ガス開発・生産動向及びコスト分析（2013年）Otto Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Otto Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- ミックスドシグナル・システム・オンチップ（SoC）の世界市場About Mixed Signal SoC Mixed signal SoC is an integrated circuit consisting of a large number of transistors on a single chip. It has both analog circuits and digital circuits. It finds applications in the areas of embedded systems. It consists of single or multiple cores of microcontroller, microprocessor, operational amplifiers, FM tuners, digital signal processor, memory blocks, oscillators, ti …
